Member Login
  1. Stocks
    2. /
  2. Pfizer Inc. (NYSE: PFE)
    3. /

NYSE:PFE (Pfizer Inc.)

About PFE

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Pfizer Inc. (NYSE: PFE) Latest News

    Investing Articles

    Is It Game Over For AstraZeneca plc Shareholders?

    | Alessandro Pasetti

    Pfizer Inc. (NYSE:PFE) is not going to make a comeback for AstraZeneca plc (LON:AZN), whose shareholders are in trouble now,…

    Read more »

    Investing Articles

    How Pfizer Inc. Could Push AstraZeneca plc Down To 3,100p

    | Alessandro Pasetti

    AstraZeneca plc (LON:AZN) is a volatile business that will disappoint shareholders if Pfizer Inc. (NYSE:PFE) doesn't make a comeback, argues…

    Read more »

    Investing Articles

    Will Pfizer Inc. Make A Bid For GlaxoSmithKline plc?

    | Rupert Hargreaves

    Will Pfizer Inc. (NYSE:PFE) bid for GlaxoSmithKline plc (LON: GSK) or AstraZeneca plc (LON: AZN)?

    Read more »

    Investing Articles

    One Reason Why AstraZeneca plc Is A Risky Bet

    | Alessandro Pasetti

    It's tough for AstraZeneca plc (LON:AZN) shareholders, argues Alessandro Pasetti.

    Read more »

    Investing Articles

    Who Can Pfizer Inc. Afford?

    | Lisa Walls-Hester

    Are Bristol-Myers Squibb Co (NYSE: BMY) or Shire PLC (LON:SHP) on Pfizer Inc. (NYSE:PFE)'s shopping list?

    Read more »

    Investing Articles

    AstraZeneca plc: Time To Cash In?

    | Alessandro Pasetti

    There are several reasons why Astra (LON:AZN) investors may want to cash in now, argues Alessandro Pasetti

    Read more »

    Company Comment

    Lessons From The Great Investors… On Coca-Cola And AstraZeneca plc

    | Mark Stones

    AstraZeneca plc (LON: AZN) and Coca-Cola are the quintessential investments of two of the all-time greats.

    Read more »

    Company Comment

    What You Need To Know About AstraZeneca plc Rejecting Pfizer’s Final Offer

    | Mark Stones

    AstraZeneca plc (LON: AZN) will live on as a standalone entity with ambitious revenue targets and a buzzing drugs pipeline.

    Read more »

    Investing Articles

    What Could Pfizer-AstraZeneca Be Like?

    | Prabhat Sakya

    What might be the positives from this potential takeover?

    Read more »

    Company Comment

    Would A Combined AstraZeneca plc/Pfizer Inc. Be Worth Owning?

    | Mark Stones

    AstraZeneca plc's (LON: AZN) strengths as a separate entity won't be best harnessed by Pfizer Inc. (NYSE:PFE)

    Read more »

    Investing Articles

    Is The Pfizer Takeover Offer for AstraZeneca plc ‘Un-American’?

    | Lisa Walls-Hester

    Pfizer Inc. (NYSE:PFE) has AstraZeneca plc (LON:AZN) firmly in its sights as a home for the $69bn of earnings it…

    Read more »